Rep. Duarte, Colleagues Urge FDA to Incentivize Preventative Research Into Valley Fever
March 07, 2024
March 07, 2024
WASHINGTON, March 7 -- Rep. John Duarte, R-California, issued the following news release on March 6, 2024:
Today, Representative John Duarte (CA-13) along with a bipartisan group of his colleagues, Representatives David Valadao (CA-22), Michelle Steel (CA-45), Juan Ciscomani (AZ-6), David Schweikert (AZ-1), and Jim Costa (CA-21), sent a letter to Commissioner Robert Califf of the U.S. Food and Drug Administration, urging the Administration to include coccidioidomycosis (Valley Fever . . .
Today, Representative John Duarte (CA-13) along with a bipartisan group of his colleagues, Representatives David Valadao (CA-22), Michelle Steel (CA-45), Juan Ciscomani (AZ-6), David Schweikert (AZ-1), and Jim Costa (CA-21), sent a letter to Commissioner Robert Califf of the U.S. Food and Drug Administration, urging the Administration to include coccidioidomycosis (Valley Fever . . .
